{"database": "lobbying", "table": "lobbying_activities", "rows": [[2635410, "5251277d-1ddc-4e4e-a54d-5a72cebdc446", "Q2", "PHARMAVITE LLC", 286074, "PHARMAVITE LLC", 2021, "second_quarter", "FOO", "H.R. 841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021, a bill to make hemp, cannabidiol derived from hemp, and any other ingredient derived from hemp lawful for use under the Federal Food, Drug, and Cosmetic Act as a dietary ingredient in a dietary supplement; all provisions relating to dietary supplements.\nS. 1698, Hemp Access and Consumer Safety Act, a bill to allow for hemp-derived cannabidiol and hemp-derived cannabidiol containing substances in dietary supplements and food; all provisions relating to dietary supplements.", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", null, 80000, 0, 0, "2021-07-12T15:28:07.197000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2635410"], "units": {}, "query_ms": 22.026633960194886, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}